- According to estimates from 7 analysts, NovoCure Limited stock's average price target has risen from $24.57 to $26.71, with forecasts ranging from $17 to $52 per share
- Based on the Jul. 22 closing price, the updated target implies approximately 72% potential upside
- Consensus rating remains at “Buy” across 7 covering analysts, with 4 Buys, 3 Holds and 0 Sells
Explore more price target data and ratings for NovoCure Limited on the , and track all previous and future analyst recommendations for NovoCure Limited in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.